We are live on ! Find out more
BMO

Beck Mack & Oliver Portfolio holdings

AUM $4.85B
1-Year Est. Return 9.66%
This Fund
S&P 500
This Quarter Est. Return
-15.9%
1 Year Est. Return
+9.66%
3 Year Est. Return
+69.39%
5 Year Est. Return
+96.17%
10 Year Est. Return
+350.87%
AUM
$2.49B
AUM Growth
-$656M
Cap. Flow
-$84.6M
Cap. Flow %
-3.39%
Top 10 Hldgs %
39.14%
Holding
242
New
12
Increased
27
Reduced
100
Closed
17

Top Buys

Rank Stock Value
1
SHW icon
Sherwin-Williams
SHW
+$27M
2
TEVA icon
Teva Pharmaceuticals
TEVA
+$10.1M
3
WAT icon
Waters Corp
WAT
+$6.41M
4
EPD icon
Enterprise Products Partners
EPD
+$3.16M
5
LH icon
Labcorp
LH
+$3.14M

Top Sells

Rank Stock Value
1
MDR
McDermott International
MDR
+$30.5M
2
SLB icon
SLB Ltd
SLB
+$24.4M
3
LBTYA icon
Liberty Global Class A
LBTYA
+$12.9M
4
QCOM icon
Qualcomm
QCOM
+$11.1M
5
MSFT icon
Microsoft
MSFT
+$7.5M

Sector Composition

Rank Sector Weight
1 Financials 30.05%
2 Healthcare 18.3%
3 Technology 12.11%
4 Communication Services 10.64%
5 Industrials 7.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UNP icon
26
Union Pacific
UNP
$174B
$32.7M 1.31%
236,487
-15,320
-6% -$2.27M
DOV icon
27
Dover
DOV
$26.7B
$31.1M 1.25%
438,133
-34,397
-7% -$2.81M
BN icon
28
Brookfield
BN
$102B
$28.9M 1.16%
2,113,118
+27,549
+1% +$411K
SHW icon
29
Sherwin-Williams
SHW
$84.8B
$26.3M 1.05%
+200,220
New +$27M
LOW icon
30
Lowe's Companies
LOW
$121B
$23.9M 0.96%
258,271
-5,456
-2% -$526K
BB icon
31
BlackBerry
BB
$4.58B
$23.7M 0.95%
3,339,142
+63,613
+2% +$560K
GILD icon
32
Gilead Sciences
GILD
$165B
$23.3M 0.93%
371,850
-30,642
-8% -$2.14M
GRFS
33
Grifois
GRFS
$5.55B
$23M 0.92%
1,254,011
-12,732
-1% -$253K
DISCK
34
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
$22.2M 0.89%
963,051
+31,250
+3% +$870K
VZ icon
35
Verizon
VZ
$197B
$21.9M 0.88%
390,266
-6,962
-2% -$395K
JEF icon
36
Jefferies Financial Group
JEF
$12.7B
$19.8M 0.8%
1,276,298
+31,473
+3% +$576K
MRK icon
37
Merck
MRK
$322B
$17.7M 0.71%
242,141
-17,888
-7% -$1.26M
USB icon
38
US Bancorp
USB
$97.9B
$16.5M 0.66%
360,904
-3,347
-0.9% -$172K
DUK icon
39
Duke Energy
DUK
$101B
$16M 0.64%
185,610
-2,166
-1% -$184K
ENB icon
40
Enbridge
ENB
$120B
$16M 0.64%
514,587
-6,772
-1% -$218K
SYY icon
41
Sysco
SYY
$40.8B
$15.2M 0.61%
243,338
-14,004
-5% -$944K
FDX icon
42
FedEx
FDX
$73B
$15M 0.6%
92,713
-1,785
-2% -$378K
XOM icon
43
ExxonMobil
XOM
$650B
$14.2M 0.57%
207,686
-28,103
-12% -$2.2M
WMT icon
44
Walmart Inc
WMT
$909B
$14.1M 0.57%
454,602
-25,734
-5% -$825K
GSAT icon
45
Globalstar
GSAT
$10.1B
$12.9M 0.52%
1,342,169
+19,600
+1% +$117K
WMB icon
46
Williams Companies
WMB
$85.8B
$12.5M 0.5%
565,918
+5,057
+0.9% +$126K
NTR icon
47
Nutrien
NTR
$33.9B
$10.8M 0.43%
229,294
-2,340
-1% -$122K
RDS.A
48
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$9.82M 0.39%
168,467
-5,150
-3% -$319K
MTB icon
49
M&T Bank
MTB
$36.3B
$9.57M 0.38%
66,879
-567
-0.8% -$90.6K
AXS icon
50
AXIS Capital
AXS
$7.81B
$9.53M 0.38%
184,606
-13,250
-7% -$724K
1
2
3 4 5

Similar funds

SCA
Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return
MCCA
Mill Creek Capital Advisors Conshohocken, Pennsylvania $4.87B AUM 17.69% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
TPCW
TD Private Client Wealth New York $4.82B AUM 15.21% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
JSTA
Japan Science & Technology Agency Tokyo, Japan $4.81B AUM 4.62% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
KCM
Kensico Capital Management Greenwich, Connecticut $4.9B AUM 41.26% 1-Year Est. Return

Beck Mack & Oliver's Q4 2018 Portfolio in Review

As of Q4 2018, Beck Mack & Oliver held 242 positions worth $2.49B, down 21% from $3.15B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Beck Mack & Oliver withdrew a net $84.6M in Q4 2018, closing 17 positions and reducing 100 holdings. Its most notable exit was McDermott International, an estimated $30.5M position sold in full.

By sector, the portfolio is most concentrated in Financials at 30% of assets, up from 29% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Beck Mack & Oliver opened a new position in Sherwin-Williams worth $26.3M.

  • Beck Mack & Oliver's largest Q4 2018 buy was Sherwin-Williams: 200,220 shares worth $26.3M.
  • Beck Mack & Oliver added most to Teva Pharmaceuticals in Q4 2018, an estimated $10.1M increase.
  • Beck Mack & Oliver's biggest Q4 2018 reduction was SLB Ltd, cutting an estimated $24.4M.
  • Beck Mack & Oliver fully exited McDermott International in Q4 2018, selling an estimated $30.5M.
  • Beck Mack & Oliver's ten largest holdings make up 39% of its $2.49B portfolio in Q4 2018.
  • Beck Mack & Oliver opened 12 new positions and closed 17 in Q4 2018.
  • Beck Mack & Oliver's portfolio value fell 21% quarter-over-quarter to $2.49B.

Based on Beck Mack & Oliver's 13F filing for Q4 2018, filed 4 Feb 2019.